Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: USPTO 148 Record romm 308-2733
1
Apr 11, 2008 10:15AM

It is about the right time frame for a decision.

A favorable decision would be bigger than the Q or the Letter.

Alot of times I've seen the 'other shoe drop' and make a stock turn 'green' in a hurry.

I've not made a comment of the Q or Goerner Shareholders letter because I didn't want to fly off the handle without chewing on the facts for a bit. I plan to shortly, but maybe a favorable USPTO would make it a moot point.

Long & Strong

Share
New Message
Please login to post a reply